Can stock pickers fight the rise of passive investors? - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Can stock pickers fight the rise of passive investors?

Active fund managers must prove their strategies are worth the cost

“Don’t look for the needle in the haystack. Just buy the haystack,” wrote John Bogle, the late founder of investment firm Vanguard. His quip is now conventional wisdom. America’s passively managed mutual funds and exchange traded funds — which mimic overall market indices — ended last year with more assets than active ones, following years of strong inflows.

Though many still tout their stock and bond picking credentials, active fund managers only rarely generate alpha (or market-beating returns). In the long term the index tends to win, substantiating Bogle’s advice. So, why risk money hoping to unearth the next Google or Amazon when it is both safer and more lucrative to be invested in everything?

That is the question active fund managers fear too many investors are now asking themselves. With the expansion of mutual index and ETF products — covering an array of assets and geographies — shifting cash into diversified trackers is simple. Investment apps allow it to be done with the flick of a finger. For households seeking to earn more from their savings, the growth of these low-cost investment vehicles is an unalloyed good.

Seeking out star or dud stocks is a costlier, more research-intensive exercise, and necessitates a higher fee-based business model. Poor long-term performance and the allure of cheaper passive strategies — which account for 40 per cent of the $45tn worldwide fund assets tracked by Morningstar, up from 14 per cent in 2008 — have eroded active managers’ inflows. Many are cutting costs and restructuring. In its annual results this week, Edinburgh-based Abrdn committed to axing 500 jobs amid large outflows.

The industry and some economists worry that the continued flow of money into buy and hold funds could harm financial markets. Beyond a certain threshold, they argue, a lack of active traders engaged in weeding out over- or underpriced companies could lead to a greater misallocation of investors’ cash.

For now this is just a theoretical concern. In practice, active managers still dominate the global industry. Finding alpha may be hard, particularly when markets are dominated by a few stocks, but opportunities have not suddenly disappeared. And big institutional investors, such as pension funds, still want to put their cash piles to work. Indeed, there remains plenty of interest in market-beating trades. For measure, hedge funds — which deploy higher-risk active strategies for accredited investors — currently outnumber Burger King outlets across the globe.

This is a cut-throat industry. Active funds are competing with hard-to-beat passive strategies, and they are engaged in a zero-sum game with other active players. For each punt, there is a loser taking the other side of the bet. According to Morningstar, in the year to June 2023, 27 per cent of actively managed global large-cap equity funds beat the equivalent passive fund. Over a 15-year timeframe, only 3 per cent have. Active traders can hardly blame investors for switching to index strategies. To survive, they must prove they can actually make money.

Slashing fees, by cutting business costs, is one option to boost the odds of making market-beating returns. Some funds have also found greater chances of beating benchmarks in bond markets and more niche corners of the stock market. Others, like Citadel or DE Shaw, have hired the brightest quant minds or tried deploying tech — from AI to high-frequency trading — to find alpha. Today’s economic uncertainty and the potential for higher-for-longer interest rates should create the volatility that hawk-eyed traders can thrive on.

Yet investors are unlikely to diverge from Bogle’s safe and sound advice without a good reason. That means if the stock pickers are to survive and thrive, they will have to work even harder to offer them one.

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

英国生物技术公司新药降低量身定制式癌症疗法副作用

Autolus用于治疗急性淋巴细胞白血病的新型Car-T细胞疗法在美国获批,该疗法与癌细胞结合所需时间更短,因此副作用更小。

前保守党财政大臣告诫工党现任勿看衰英国前景

杰里米•亨特表示,英国在关键增长领域表现强劲,应该停止贬低自己。

Lex专栏:游戏机制造商在低迷市场中表现强劲

虽然游戏机老化通常意味着游戏公司收入持续下降,但多年未推出新产品的索尼和任天堂等游戏公司仍表现强劲。

为年度展望报告辩护

巴克兰:定期回顾投资框架以及进行经济和市场展望是一项良好的做法。

企业长寿的奥秘为何对投资者很重要

长寿公司除了具有凝聚力、宽容度和财务保守等特征外,几乎没有什么共同点。
1天前

特朗普上台能否解决加拿大经济疲软问题?

经济学家表示,来自美国的冲击可能会使该国经济摆脱麻木状态。
设置字号×
最小
较小
默认
较大
最大
分享×